Skip to main content

Table 1 Population statistics of patients with newly diagnosed GBM

From: Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients

Population statistics Category Absolute Percentage
Median age at diagnosis   61.0  
Average age at death   60.5  
Gender M 44 60 %
  F 29 40 %
Extent of resection GTR 38 52 %
  STR 24 33 %
  Biopsy 11 15 %
Median RT dose   6000  
Concurrent agents Temozolomide alone 39 53 %
  Temozolomide and Bevacizumab 34 47 %
Smoker No 43 60 %
  Yes 29 40 %
HTN No 32 44 %
  Yes 41 56 %
BMI Normal (<25) 17 23 %
  Overweight (25–30) 37 51 %
  Obese (>30) 19 26 %
DM No 63 86 %
  Yes 10 14 %
Hyperlipidemia No 46 63 %
  Yes 27 37 %
Dexamethasone during RT No 37 51 %
  Yes 36 49 %